Selected article for: "clinical study and immune system"
Author: Smith, Steven B.; Dampier, William; Tozeren, Aydin; Brown, James R.; Magid-Slav, Michal
Title: Identification of Common Biological Pathways and Drug Targets Across Multiple Respiratory Viruses Based on Human Host Gene Expression Analysis
  • Document date: 2012_3_14
    • ID: 100ir651_4
    Snippet: Individuals may experience a co-infection or sequential infections of multiple viruses or bacteria which can complicate both disease diagnosis and drug prescription decisions. Furthermore, patients infected by multiple pathogens may have further complications due to drug-drug interactions, cumulative drug toxicities and immune system suppression, as observed during HIV and Mycobacterium tuberculosis co-infections [18, 19] . Indeed, a study in chi.....
    Document: Individuals may experience a co-infection or sequential infections of multiple viruses or bacteria which can complicate both disease diagnosis and drug prescription decisions. Furthermore, patients infected by multiple pathogens may have further complications due to drug-drug interactions, cumulative drug toxicities and immune system suppression, as observed during HIV and Mycobacterium tuberculosis co-infections [18, 19] . Indeed, a study in children under five years showed pervasive clinical occurrences of co-infections involving combinations of RSV, HRV, Paramyxoviridae Parainfluenza Virus, FLU, Coronaviridae SARS-Coronavirus (CORON), Paramyxoviridae Metapneumonia virus (MPNEU), Parvoviridae Human Bocavirus and ADENO [4] . Therefore, in addition to minimizing drug resistance, there is a need for new therapeutic approaches to safely and effectively treat co-infections by multiple viral and/or bacterial pathogens, particularly where strain-specific diagnostics or treatments are unavailable.

    Search related documents:
    Co phrase search for related documents
    • bacterial pathogen and co infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • bacterial pathogen and disease diagnosis: 1
    • bacterial pathogen and drug drug: 1
    • bacterial pathogen and drug resistance: 1, 2, 3
    • bacterial pathogen and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • child study and clinical occurrence: 1
    • child study and co infection: 1
    • clinical occurrence and co infection: 1, 2, 3, 4, 5
    • clinical occurrence and drug resistance: 1
    • clinical occurrence and immune system: 1
    • co infection and disease diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • co infection and drug drug: 1, 2, 3, 4, 5
    • co infection and drug drug interaction: 1, 2
    • co infection and drug resistance: 1, 2, 3, 4, 5, 6, 7
    • co infection and drug toxicity: 1
    • co infection and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • co infection and immune system suppression: 1
    • co infection treat and drug drug: 1
    • disease diagnosis and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25